Altered Functions of Neutrophils in Two Chinese Patients With Severe Congenital Neutropenia Type 4 Caused by Mutations
Overview
Authors
Affiliations
Background: SCN4 is an autosomal recessive disease caused by mutations in the gene. The clinical, molecular, and immunological features; function of neutrophils; and prognosis of patients with SCN4 have not been fully elucidated.
Methods: Two Chinese pediatric patients with mutations were enrolled in this study. Clinical data, genetic and immunologic characteristics, and neutrophil function were evaluated in patients and controls before and after granulocyte colony-stimulating factor (G-CSF) treatment.
Results: Both patients had histories of pneumonia, inguinal hernia, cryptorchidism, and recurrent oral ulcers. Patient 1 also had asthma and otitis media, and patient 2 presented with prominent ectatic superficial veins and inflammatory bowel disease. DNA sequencing demonstrated that both patients harbored heterozygous gene mutations. Spontaneous and FAS-induced neutrophil apoptosis were significantly increased in patients, and improved only slightly after G-CSF treatment, while neutrophil respiratory burst and neutrophil extracellular traps production remained impaired in patients after G-CSF treatment.
Conclusion: G-CSF treatment is insufficient for patients with SCN4 patients, who remain at risk of infection. Where possible, regular G-CSF treatment, long-term prevention of infection, are the optimal methods for cure of SCN4 patients. It is important to monitor closely for signs of leukemia in SCN4 patients. Once leukemia occurs in SCN4 patients, hematopoietic stem cell transplantation is the most important choice of treatment.
Molecular and Clinical Characterization of a Founder Mutation Causing G6PC3 Deficiency.
Zhen X, Betti M, Kars M, Patterson A, Medina-Torres E, Scheffler Mendoza S J Clin Immunol. 2024; 45(1):53.
PMID: 39630167 PMC: 11618172. DOI: 10.1007/s10875-024-01836-0.
Molecular and clinical characterization of a founder mutation causing G6PC3 deficiency.
Zhen X, Betti M, Kars M, Patterson A, Medina-Torres E, Scheffler Mendoza S Res Sq. 2024; .
PMID: 39041036 PMC: 11261954. DOI: 10.21203/rs.3.rs-4595246/v1.
Molecular and clinical characterization of a founder mutation causing G6PC3 deficiency.
Zhen X, Betti M, Kars M, Patterson A, Medina-Torres E, Scheffler Mendoza S medRxiv. 2024; .
PMID: 38798393 PMC: 11118594. DOI: 10.1101/2024.05.13.24307299.
Revisiting the immunopathology of congenital disorders of glycosylation: an updated review.
Pascoal C, Francisco R, Mexia P, Pereira B, Granjo P, Coelho H Front Immunol. 2024; 15:1350101.
PMID: 38550576 PMC: 10972870. DOI: 10.3389/fimmu.2024.1350101.
A metabolic perspective of the neutrophil life cycle: new avenues in immunometabolism.
Thind M, Uhlig H, Glogauer M, Palaniyar N, Bourdon C, Gwela A Front Immunol. 2024; 14:1334205.
PMID: 38259490 PMC: 10800387. DOI: 10.3389/fimmu.2023.1334205.